Hippo pathway activation drives fibrogenic remodelling in influenza A virus-infected lung fibroblasts.

Authors

Yasmina Reisser, Elaine Winkler, Julia Hoffmann, Nilima Dinesh Kumar, Antje Häder, Susanne M Lang, Bettina Löffler, Stefanie Deinhardt-Emmer

Published in

ERJ open research. Volume 12. Issue 3. Epub Jun 17, 2026.

Abstract

Pulmonary fibrosis is a progressive and often fatal interstitial lung disease with largely undefined aetiology. Alveolar macrophages and lung fibroblasts play key roles in maladaptive tissue remodelling; however, the cellular and molecular mechanisms underlying their coordinated fibrotic responses remain incompletely characterised.
Following influenza A virus (IAV) infection, viral load, cytokine release and transcriptomic changes were analysed. To assess indirect effects on fibrosis, IMR-90 fibroblasts were treated with conditioned media from infected alveolar macrophage-like (AML) cells. Direct IAV infection of IMR-90 cells was also performed to evaluate changes in the Hippo signalling pathway and fibrotic marker expression using microarray and transcriptomic approaches.
For the first time, AML cells were successfully infected with IAV, validating this model for studying pathogen-driven exacerbation of fibrosis in ageing lungs. Transcriptomic and protein-level analyses revealed that IAV promotes fibrogenesis in fibroblasts through two distinct mechanisms: 1) indirectly, via pro-inflammatory and pro-fibrotic mediators released by infected macrophages; and 2) directly, through viral-induced modulation of the Hippo signalling pathway, resulting in upregulation of key fibrotic markers such as CTGF, fibronectin and collagen I.
These findings provide novel mechanistic insights into macrophage-fibroblast crosstalk in the context of viral infection and fibrosis. They suggest that dysregulation of these interactions contributes to the susceptibility of the ageing lung to fibrotic remodelling following respiratory viral infections and may inform future therapeutic interventions targeting Hippo pathway signalling.

PMID:
42311875
Bibliographic data and abstract were imported from PubMed on 14 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.